Description
The Department of Veterans Affairs is conducting market research for a cloud‑based, AI‑enhanced digital tele‑pathology solution (NDTP‑AI) that will detect prostate and gastric cancers, integrate with the existing Philips IntelliSite Pathology System, and store whole‑slide images in the VA Enterprise Cloud. The RFI is informational only; no contract award or funding is disclosed yet, but a future competitive procurement is planned as a Service‑Disabled Veteran‑Owned Small Business set‑aside under the NASA SEWP‑V GWAC.
• Required solution: FDA‑cleared AI pathology software for prostate and gastric cancer detection, integrated with Philips IntelliSite, with secure VA‑cloud storage.
• Contract expectations: 12‑month base period with up to four 12‑month option extensions; 99.99 % system uptime; AI accuracy ≥ 92 % correct predictions, ≥ 90 % cancer detection.
• Vendor eligibility: Must meet extensive VA security, privacy, and compliance standards (FIPS, NIST, HIPAA, VA Critical Security Controls) and be able to operate within the VA Enterprise Cloud (AWS).
• Submission: Responses due June 23 2026, ≤ 15 pages, PDF format, ≤ 5 MB per email. No budget disclosed; respondents must provide a rough order‑of‑magnitude cost estimate for implementation, licensing, cloud storage, and support.